KLK3 and prostate carcinoma: Nevertheless it is well known that the pretreatment (primary) PSA level closely correlates with the prostate cancer progression: serum PSA level increase after radical treatment is the main hallmark of tumor recurrence; the dynamics of PSA concentration in response to treatment reflects the effectiveness of therapy [1].